chartexchange

ENGNW
enGene Therapeutics Inc. Warrants
stockNASDAQWarrant

At CloseNov 20, 2026
0.133USD-17.545%(-0.028)33,248

ENGNW Financials

In Q3 FY 2026 (ended ), enGene Therapeutics Inc. Warrants (ENGNW) reported net income of −$32.5M, operating cash flow of −$18.95M, and assets of $288.32M (filed ).

Loading financial statements…